Patents Assigned to Kite Pharma, Inc.
  • Methods of Conditioning Patients for T Cell Therapy
    Publication number: 20160346326
    Abstract: The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Applicants: Kite Pharma, Inc., National Cancer Institute
    Inventors: Adrian BOT, Jeffrey S. WIEZOREK, William GO, Rajul JAIN, James N. KOCHENDERFER, Steven A. ROSENBERG